Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	14.81	14.56	38.83	12.6	129.26
Short-Term Investments	37.75	37.93	12.09	82.44	0
Cash & Cash Equivalents	52.56	52.49	50.92	95.03	129.26
Cash Growth	0.15%	3.09%	-46.42%	-26.48%	52.13%
Receivables	2.44	0.19	3	0	0
Other Current Assets	0.73	0.42	2.38	2.71	3.13
Total Current Assets	55.74	53.1	56.29	97.74	132.39
Property, Plant & Equipment	7.99	11.07	21.74	18.35	21.2
Goodwill and Intangibles	0	0	1.38	33.97	68.64
Other Long-Term Assets	0.28	0.04	0.17	1.14	1.14
Total Long-Term Assets	8.27	11.12	23.29	53.46	90.99
Total Assets	64	64.21	79.59	151.2	223.38
Accounts Payable	1.86	5.97	8.15	4.7	31.16
Deferred Revenue	0	0	0	0.3	0.3
Current Debt	1	1.77	1.82	2.04	1.7
Other Current Liabilities	10.57	0.03	6.65	34.93	5.54
Total Current Liabilities	13.42	7.78	16.62	41.96	38.7
Long-Term Debt	4.4	5.85	7.56	6.69	6.25
Other Long-Term Liabilities	31.35	23.82	13.04	0	0
Total Long-Term Liabilities	35.75	29.67	20.6	6.69	6.25
Total Liabilities	49.18	37.45	37.22	48.65	44.95
Total Debt	5.4	7.63	9.38	8.73	7.95
Debt Growth	-29.20%	-18.67%	7.41%	9.82%	-
Retained Earnings	-749.52	-695.34	-655.64	-570.7	-486.47
Comprehensive Income	-0.07	-0.13	-0.03	-0.01	0
Shareholders' Equity	14.83	26.76	42.37	102.55	178.43
Net Cash / Debt	47.16	44.86	41.54	86.3	121.31
Net Cash / Debt Growth	5.14%	8.00%	-51.87%	-28.86%	42.77%
Net Cash Per Share	2.21	5.71	10.55	23.28	60.23
Working Capital	42.32	45.32	39.67	55.78	93.69
Book Value Per Share	0.69	3.40	10.76	27.67	88.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).